Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2006-05-23
2006-05-23
Kumar, Shailendra (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S534000, C514S563000, C514S620000
Reexamination Certificate
active
07049344
ABSTRACT:
A method is described for inhibiting urokinase plasminogen activator in a human or animal patient. The method involves administering to the patient a urokinase plasminogen activator inhibiting effective amount of a compound of the formula (I):
REFERENCES:
patent: 5914319 (1999-06-01), Schacht et al.
patent: 6248738 (2001-06-01), Dickinson et al.
patent: 6534546 (2003-03-01), Honda et al.
patent: WO 99 20608 (1999-04-01), None
patent: WO 00 04954 (2000-02-01), None
patent: WO 01 14324 (2001-03-01), None
S. Sperl et al., “(4-Aminomethyl)phenylguanidine Derivatives As Nonpeptidic Highly Selective Inhibitors of Human Urokinase,” Proceedings of the National Academy of Sciences of USA, National Academy of Science, Washington, US, vol. 97, No. 10, May 9, 2000, pp. 5113-5118, XP002169711.
R. Rai et al., “Guanidinophenyl-Substituted Enol Lactones As Selective Mechanism-Based Inhibitors of Trypsin-Like Serine Proteases,” Journal of Medicinal Chemistry, American Chemical Society, Washington, US, vol. 35, No. 22, 1992, pp. 4150-4159, XP000978771.
Y, Heechung et al., “Selective Inhibition of Urokinase By Substituted Phenylguanidines: Quantitative Structure-Activity Relationship Analyses,” Journal of Medicinal Chemistry, American Chemical Society, Washington, US, vol. 33, No. 11, 1990, pp. 2956-2961, XP002059264.
Arroyo De Prada Nuria
Bode Wolfram
Huber Robert
Jacob Uwe
Magdolen Viktor
Kumar Shailendra
Max-Planck-Gessellschaft zur Forderung der Wissenschaften E.V.
Millen White Zelano & Branigan P.C.
Wilex Biotechnology GmbH
LandOfFree
Highly selective inhibitors of the urokinase plasminogen... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Highly selective inhibitors of the urokinase plasminogen..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Highly selective inhibitors of the urokinase plasminogen... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3630212